InMed Pharmaceuticals Inc. (INM)
NASDAQ: INM · Real-Time Price · USD
2.080
+0.010 (0.48%)
Apr 1, 2025, 4:00 PM EDT - Market closed
InMed Pharmaceuticals Employees
InMed Pharmaceuticals had 13 employees as of June 30, 2024. The number of employees did not change compared to the previous year.
Employees
13
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$371,693
Profits / Employee
-$608,725
Market Cap
2.51M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
INM News
- 6 weeks ago - InMed Reports Second Quarter Fiscal 2025 Financial Results and Provides Business Update - Newsfile Corp
- 2 months ago - InMed Announces INM-089 Intravitreal Formulation in the Treatment of Dry Age-Related Macular Degeneration - Newsfile Corp
- 2 months ago - InMed Pharmaceuticals Announces Granting of Patent for Novel Compounds - Newsfile Corp
- 2 months ago - InMed's INM-901 Demonstrates Statistically Significant Reduction in Neuroinflammation in a Long-Term Preclinical Alzheimer's Disease Study - Newsfile Corp
- 3 months ago - InMed Announces Results of 2024 Annual General Meeting - Newsfile Corp
- 3 months ago - InMed Enters Into Standby Equity Purchase Agreement - Newsfile Corp
- 4 months ago - InMed Announces Publication of Study on Anti-Inflammation by Modulation of Endocannabinoid System - Newsfile Corp
- 4 months ago - InMed Reports First Quarter Fiscal 2025 Financial Results and Provides Business Update - Newsfile Corp